Or where the heck they would get funding for $240,000,000 inventory.
They carefully used the word “COMMENCES” - that could mean any amount they were starting with and the $240,000,000 would be a goal to reach. If ever.
Arrayit Corporation
@arrayit
·
Aug 8
Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma
And from Trav email to Mark: (red txt is what mark said apparently)
Judging from last manufacturing run, this should take about 17 days or so, is that accurate?
The 240m production run is for our test kits (blood cards, lancets, swabs etc) collected by our clinics and billed at list price.
I know you have said information will be revealed in upcoming 8k’s, can you guesstimate when the next 8K will be? Not sure if that is confidential info or not....
8-K release dates are confidential per our new NASDAQ preparation guidelines.
Congrats anyway, that’s a huge number, to have $240,000,000 in inventory speaks volumes about what Arrayit is capable of.
We are seeing tremendous growth in our clinical segment consistent with the size of the allergy and asthma testing markets. These are exciting times for the company.
——
BILLED AT LIST PRICE??? what did that mean? Are they discounted for clinics? And that’s not the actual amount?
Why is it always about BILLINGS and nothing about actual revenue?